We are live on ! Find out more
GT

Glenmede Trust Portfolio holdings

AUM $20.4B
This Fund
S&P 500
This Quarter Est. Return
-0.12%
1 Year Est. Return
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$13.9B
AUM Growth
+$146M
Cap. Flow
+$287M
Cap. Flow %
2.07%
Top 10 Hldgs %
11.54%
Holding
3,080
New
521
Increased
857
Reduced
739
Closed
172

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$44.4M
2
TXN icon
Texas Instruments
TXN
+$39.6M
3
CHD icon
Church & Dwight Co
CHD
+$39.1M
4
BA icon
Boeing
BA
+$34.3M
5
DIS icon
Walt Disney
DIS
+$34M

Top Sells

Rank Stock Value
1
ORCL icon
Oracle
ORCL
+$47.1M
2
AMP icon
Ameriprise Financial
AMP
+$42.3M
3
NTAP icon
NetApp
NTAP
+$38.1M
4
SYK icon
Stryker
SYK
+$35.6M
5
BALL icon
Ball Corp
BALL
+$34.9M

Sector Composition

Rank Sector Weight
1 Technology 15.68%
2 Healthcare 14.66%
3 Industrials 11%
4 Financials 10.76%
5 Consumer Discretionary 9.74%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CP icon
1426
Canadian Pacific Kansas City
CP
$81.4B
$61K ﹤0.01%
1,935
-290
-13% -$10.4K
RGLD icon
1427
Royal Gold
RGLD
$16.8B
$61K ﹤0.01%
1,000
-91
-8% -$5.83K
RH icon
1428
RH
RH
$3.46B
$61K ﹤0.01%
639
-27
-4% -$2.49K
FNM.PRS
1429
DELISTED
FEDERAL NATIONAL MORTGAGE ASSOCIATION PFD SER S (USA)
FNM.PRS
$61K ﹤0.01%
16,400
CMT icon
1430
Core Molding Technologies
CMT
$208M
$60K ﹤0.01%
2,650
-20,000
-88% -$461K
EEMV icon
1431
iShares MSCI Emerging Markets Min Vol Factor ETF
EEMV
$3.39B
$60K ﹤0.01%
1,041
+165
+19% +$10K
SRPT icon
1432
Sarepta Therapeutics
SRPT
$1.6B
$60K ﹤0.01%
2,000
-5,000
-71% -$102K
TDW icon
1433
Tidewater
TDW
$3.81B
$60K ﹤0.01%
83
-79
-49% -$64.2K
AWAY
1434
DELISTED
HOMEAWAY INC COM
AWAY
$60K ﹤0.01%
1,970
-1,120
-36% -$33.4K
BEP icon
1435
Brookfield Renewable
BEP
$9.57B
$59K ﹤0.01%
+3,753
New +$62.3K
EWT icon
1436
iShares MSCI Taiwan ETF
EWT
$9.51B
$59K ﹤0.01%
1,876
POWR
1437
DELISTED
POWERSECURE INTL INC COM STK (DE)
POWR
$59K ﹤0.01%
4,000
CPT icon
1438
Camden Property Trust
CPT
$11.3B
$58K ﹤0.01%
799
+759
+1,898% +$57.5K
GATX icon
1439
GATX Corp
GATX
$6.59B
$58K ﹤0.01%
1,100
MDU icon
1440
MDU Resources
MDU
$4.38B
$58K ﹤0.01%
7,890
-3,169
-29% -$25.5K
SPLK
1441
DELISTED
Splunk Inc
SPLK
$58K ﹤0.01%
860
XEC
1442
DELISTED
CIMAREX ENERGY CO
XEC
$58K ﹤0.01%
531
-75
-12% -$8.96K
AMID
1443
DELISTED
American Midstream Partners, LP
AMID
$58K ﹤0.01%
3,700
CSGS
1444
DELISTED
CSG Systems International
CSGS
$57K ﹤0.01%
1,833
-991
-35% -$30.6K
IEZ icon
1445
iShares US Oil Equipment & Services ETF
IEZ
$355M
$57K ﹤0.01%
1,200
SJT
1446
San Juan Basin Royalty Trust
SJT
$119M
$57K ﹤0.01%
5,400
+3,900
+260% +$43.2K
TYG
1447
Tortoise Energy Infrastructure Corp
TYG
$1.11B
$57K ﹤0.01%
394
TLP
1448
DELISTED
Transmontaigne
TLP
$57K ﹤0.01%
1,530
PSK icon
1449
State Street SPDR ICE Preferred Securities ETF
PSK
$691M
$56K ﹤0.01%
+1,300
New +$57.8K
WGL
1450
DELISTED
Wgl Holdings
WGL
$56K ﹤0.01%
1,039
+39
+4% +$2.18K

Similar funds

Glenmede Trust's Q2 2015 Portfolio in Review

As of Q2 2015, Glenmede Trust held 3,080 positions worth $13.9B, up 1.1% from $13.7B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Glenmede Trust's Q2 2015 filing shows 521 new, 857 increased, 739 reduced and 172 closed positions. Its largest new stake was Iridium Communications: 2,746,232 shares worth $25M. The largest sale was Oracle, an estimated $47.1M.

By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 16% a quarter earlier, followed by Healthcare and Industrials.

  • Glenmede Trust's largest Q2 2015 buy was Iridium Communications: 2,746,232 shares worth $25M.
  • Glenmede Trust added most to Microsoft in Q2 2015, an estimated $44.4M increase.
  • Glenmede Trust's biggest Q2 2015 reduction was Oracle, cutting an estimated $47.1M.
  • Glenmede Trust fully exited Triumph Group in Q2 2015, selling an estimated $30M.
  • Glenmede Trust's ten largest holdings make up 12% of its $13.9B portfolio in Q2 2015.
  • Glenmede Trust opened 521 new positions and closed 172 in Q2 2015.
  • Glenmede Trust's portfolio value rose 1.1% quarter-over-quarter to $13.9B.

Based on Glenmede Trust's 13F filing for Q2 2015, filed 22 Jul 2015.